Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H34O2 |
Molecular Weight | 258.44 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCC(O)CO
InChI
InChIKey=BTOOAFQCTJZDRC-UHFFFAOYSA-N
InChI=1S/C16H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16(18)15-17/h16-18H,2-15H2,1H3
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Allergic contact dermatitis from sodium dihydroxycetyl phosphate, a new cosmetic allergen? | 2001 Sep |
|
[Coprecipitation of the Pseudomonas fluorescens lipase with hydrophobic compounds as an approach to its immobilization for catalysis in nonaqueous media]. | 2002 Jan-Feb |
|
Polyol Process Synthesis of Monodispersed FePt Nanoparticles. | 2004 May 20 |
|
Shape-controlled synthesis and shape-induced texture of MnFe2O4 nanoparticles. | 2004 Sep 22 |
|
Iron oxide shell as the oxidation-resistant layer in SmCo5 @ Fe2O3 core-shell magnetic nanoparticles. | 2007 Jan |
|
Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. | 2008 Oct 2 |
|
A reduction pathway in the synthesis of PbSe nanocrystal quantum dots. | 2009 Aug 5 |
|
Structural characterization and self-assembly into superlattices of iron oxide-gold core-shell nanoparticles synthesized via a high-temperature organometallic route. | 2009 Jan 7 |
|
Size-controlled syntheses and hydrophilic surface modification of Fe3O4, Ag, and Fe3O4/Ag heterodimer nanocrystals. | 2010 Dec 7 |
|
Monolayer-directed assembly and magnetic properties of FePt nanoparticles on patterned aluminum oxide. | 2010 Mar 19 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
230-030-1
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
C470411
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
1H07JK4G0C
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
71525
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
1H07JK4G0C
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
75586
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
98037
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
1592894
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID60884343
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY | |||
|
6920-24-7
Created by
admin on Sat Dec 16 00:38:56 GMT 2023 , Edited by admin on Sat Dec 16 00:38:56 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD